A phase 2 study has suggested that the glycoprotein (gp) IIb/IIIa blocker eptifibatide can be safely combined with a reduced dose of tPA in the treatment of acute ischemic stroke, and there was a ...

May 14, 2010 — A new pooled analysis of randomized trials of tissue plasminogen activator (tPA) in the treatment of acute ischemic stroke, now expanded to include more recent trials, confirms the ...

Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, ...

Stroke victims treated with TPA were twice as likely to have a good outcome as those who were not. The Food and Drug Administration approved it for stroke the next year, and a move grew to treat ...

FRESNO, Calif. (KFSN) -- Stroke is the third leading cause of death in the U.S. claiming the lives of more than 140,000 Americans each year. But many lives could be spared if treatment was given ...

Emergency mobile stroke unit. Ambulance van furnishes services to diagnose stroke patients. Two neurologists discuss the barriers to timely tPA administration in acute stroke, including the ...

Ischemic stroke - it's the category (the other is hemorrhagic) into which about 85 percent of all strokes fall. Blood suddenly stops going to a specific area of the brain because of a blood clot, thus ...

Implementing a quality initiative in more than 71,000 stroke patients, was associated with improvement in the time to treatment and a lower risk of death and other complications, found in a study.

My neighbor had a stroke and received a “clot buster” medication. Then, I found out my uncle had a surgery after a stroke.